AstraZeneca (Q731938)

https://www.lanacion.com.ar/politica/alberto-fernandez-xx-nid2419369

bioteknologi

0 rujukan

tarikh penubuhan

1913

1 rujukan

https://www.astrazeneca.ch/en/about-us/our-history.html

3 Oktober 2023

gambar logo

Astrazeneca text logo.svg
300 × 43; 7 KB

0 rujukan

gambar

AstraZeneca HQ in Cambridge UK.jpg
4,032 × 3,024; 3.83 MB

1 rujukan

Wikipedia Bahasa Inggeris

URL import Wikimedia

https://en.wikipedia.org/w/index.php?title=AstraZeneca&oldid=1058759419

nama rasmi

AstraZeneca PLC (Inggeris)

1999

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Zeneca Group PLC (Inggeris)

Februari 1993

tarikh tamat

1999

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

ketua pegawai eksekutif

Pascal Soriot

2006

1 rujukan

https://www.astrazeneca.com/our-company/leadership.html

pengerusi

Leif Johansson ^Inggeris

26 April 2012

1 rujukan

https://beta.companieshouse.gov.uk/officers/UR_GVtQ1C0JXN1sNFXzVIMUQz4I/appointments

ahli lembaga

Leif Johansson ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Graham Chipchase ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Geneviève Berger ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Sheri McCoy ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Tony Mok ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Marcus Wallenberg ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 rujukan

Wikipedia Bahasa Inggeris

bentuk sah

public limited company ^Inggeris

1 rujukan

Wikipedia bahasa Jerman

jumlah aset

61,377,000,000 Dolar Amerika Syarikat

31 Disember 2019

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

60,651,000,000 Dolar Amerika Syarikat

31 Disember 2018

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

53,354,000,000 Dolar Amerika Syarikat

31 Disember 2017

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

62,526,000,000 Dolar Amerika Syarikat

31 Disember 2016

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

60,056,000,000 Dolar Amerika Syarikat

31 Disember 2015

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

jumlah ekuiti

14,596,000,000 Dolar Amerika Syarikat

31 Disember 2019

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

14,044,000,000 Dolar Amerika Syarikat

31 Disember 2018

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

16,642,000,000 Dolar Amerika Syarikat

31 Disember 2017

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

16,669,000,000 Dolar Amerika Syarikat

31 Disember 2016

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

18,509,000,000 Dolar Amerika Syarikat

31 Disember 2015

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

jumlah hasil

24,384,000,000 Dolar Amerika Syarikat

2019

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

22,090,000,000 Dolar Amerika Syarikat

2018

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

22,465,000,000 Dolar Amerika Syarikat

2017

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

23,002,000,000 Dolar Amerika Syarikat

2016

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

24,708,000,000 Dolar Amerika Syarikat

2015

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

untung bersih

1,227,000,000 Dolar Amerika Syarikat

2019

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

2,050,000,000 Dolar Amerika Syarikat

2018

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

2,868,000,000 Dolar Amerika Syarikat

2017

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

6,406,000,000 Dolar Amerika Syarikat

2016

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

2,826,000,000 Dolar Amerika Syarikat

2015

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

pendapatan kendalian

2,924,000,000 Dolar Amerika Syarikat

2019

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

3,387,000,000 Dolar Amerika Syarikat

2018

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

3,677,000,000 Dolar Amerika Syarikat

2017

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

4,902,000,000 Dolar Amerika Syarikat

2016

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

4,116,000,000 Dolar Amerika Syarikat

2015

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 rujukan

Wikipedia Bahasa Itali

dimiliki oleh

BlackRock

proportion ^Inggeris

7.69 peratus

4 Disember 2009

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Investor AB

proportion ^Inggeris

3.93 peratus

3 April 2019

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Capital Group Companies ^Inggeris

proportion ^Inggeris

4.86 peratus

17 Julai 2018

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Wellington Management Company ^Inggeris

proportion ^Inggeris

5.89 peratus

3 Oktober 2019

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

pertubuhan induk

tiada nilai

0 rujukan

anak syarikat

AstraZeneca Canada ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

AstraZeneca PTY ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

AstraZeneca Korea ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

AstraZeneca ^Inggeris

2 rujukan

ID GRID

grid.418151.8

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

AstraZeneca India ^Inggeris

2 rujukan

ID GRID

grid.459399.b

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

AstraZeneca ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

AstraZeneca ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

AstraZeneca Farmaceutica Spain ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

AstraZeneca Czech Republic ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Cambridge Antibody Technology ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

AstraZeneca (United States) ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Amylin Pharmaceuticals ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Acerta Pharma ^Inggeris

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

empunya

Archigen Biotech ^Inggeris

proportion ^Inggeris

50 peratus

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Montrose Chemical Corporation of California ^Inggeris

proportion ^Inggeris

50 peratus

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

ADC Therapeutics ^Inggeris

proportion ^Inggeris

6.66 peratus

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Circassia Pharmaceuticals ^Inggeris

proportion ^Inggeris

18.9 peratus

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Entasis Therapeutics ^Inggeris

proportion ^Inggeris

16.29 peratus

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Moderna

proportion ^Inggeris

7.65 peratus

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

PhaseBio Pharmaceuticals (United States) ^Inggeris

proportion ^Inggeris

10.44 peratus

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

52°10'29.3124"N, 0°7'58.1826"E

poskod

CB2 0AA

negara

United Kingdom

0 rujukan

Cambridge Biomedical Campus ^Inggeris

0 rujukan

AZN

6 April 1999

1 rujukan

Polygon.io ^Inggeris

Astrazeneca PLC

20 Februari 2021

AZN

0 rujukan

Nasdaq Stockholm AB ^Inggeris

simbol ticker

AZN

0 rujukan

bilangan pekerja

70,600

2019

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

64,600

2017

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

61,100

2016

1 rujukan

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

0 rujukan

180,898 tonne of carbon dioxide equivalent

Scope 1 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

19,940 tonne of carbon dioxide equivalent

peranan objek

Scope 2 market-based ^Inggeris

1 Januari 2023

tarikh tamat

31 Disember 2023

kaedah penentuan

GHG Protocol ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

183,332 tonne of carbon dioxide equivalent

peranan objek

Scope 2 location-based ^Inggeris

1 Januari 2023

tarikh tamat

31 Disember 2023

kaedah penentuan

GHG Protocol ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

6,736,878 tonne of carbon dioxide equivalent

Scope 3 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

4,622,257 tonne of carbon dioxide equivalent

Scope 3 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

Purchased goods and services ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

81,938 tonne of carbon dioxide equivalent

Scope 3 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

Capital goods ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

52,634 tonne of carbon dioxide equivalent

Scope 3 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

Fuel- and energy-related activities ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

241,422 tonne of carbon dioxide equivalent

Scope 3 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

Upstream transportation and distribution ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

19,043 tonne of carbon dioxide equivalent

Scope 3 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

Waste generated in operations ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

155,443 tonne of carbon dioxide equivalent

Scope 3 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

Business travel ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

50,827 tonne of carbon dioxide equivalent

Scope 3 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

Employee commuting ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

30,101 tonne of carbon dioxide equivalent

Scope 3 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

Upstream leased assets ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

135,689 tonne of carbon dioxide equivalent

Scope 3 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

Downstream transportation and distribution ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

1,330,844 tonne of carbon dioxide equivalent

Scope 3 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

Use of sold products ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

14,579 tonne of carbon dioxide equivalent

Scope 3 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

End-of-life treatment of sold products ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

2,101 tonne of carbon dioxide equivalent

Scope 3 ^Inggeris

1 Januari 2023

31 Disember 2023

GHG Protocol ^Inggeris

Downstream leased assets ^Inggeris

1 rujukan

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

barang atau bahan keluaran

ubat

0 rujukan

tapak web rasmi

http://www.astrazeneca.com/

bahasa karya atau nama

bahasa Inggeris

1 rujukan

Wikipedia Bahasa Inggeris

dijelaskan di URL

http://www.fundinguniverse.com/company-histories/astrazeneca-plc-history/

0 rujukan

dijelaskan oleh sumber

Medvik ^Inggeris

https://www.medvik.cz/link/nlk20030129777

AstraZeneca

URL

1 rujukan

Medvik ^Inggeris

9 Oktober 2020

pengikut media sosial

228,185

10 Januari 2021

0 rujukan

142,600

10 Mei 2018

0 rujukan

298,516

21 Februari 2022

0 rujukan

304,575

Vaksin COVID-19 Oxford–AstraZeneca

7 Februari 2023

0 rujukan

berbeza daripada

1 rujukan

https://pl.wikipedia.org/w/index.php?title=AstraZeneca&oldid=63365095

Wikipedia bahasa Poland

URL import Wikimedia

kategori Commons

AstraZeneca

0 rujukan

kategori utama topik

Category:AstraZeneca ^Inggeris

0 rujukan

Pengenal pasti

Legal Entity Identifier ^Inggeris

PY6ZZQWO2IZFZC3IOL08

0 rujukan

ISIN

GB0009895292

1 rujukan

Wikipedia bahasa Jerman

ID VIAF

154100491

1 rujukan

Fail Kewibawaan Antarabangsa Maya

5 Ogos 2015

1 rujukan

10.6084/M9.FIGSHARE.4539889

CANTIC ID ^Inggeris

1 rujukan

1 rujukan

BnF authorities ^Inggeris

26 Ogos 2015

ID GND

10037826-2

1 rujukan

https://de.wikipedia.org/w/index.php?title=AstraZeneca&oldid=205973128

Wikipedia bahasa Jerman

URL import Wikimedia

ID FAST

1995186

0 rujukan

ID Perpustakaan Negara Israel

987011066432105171

1 rujukan

ID kewibawaan Perpustakaan Kongres

National Library of Israel Names and Subjects Authority File ^Inggeris

no2010135192

AstraZeneca (Firm)

1 rujukan

Fail Kewibawaan Antarabangsa Maya

6 Mac 2019

AstraZeneca

1 rujukan

ID VIAF

154100491

Fail Kewibawaan Antarabangsa Maya

ID dalam talian Brockhaus Enzyklopädie

17 Disember 2018

Portuguese National Library author ID ^Inggeris

0 rujukan

1 rujukan

BnF authorities ^Inggeris

26 Ogos 2015

1 rujukan

BBC News topic ID ^Inggeris

cz4pr2gd52lt

0 rujukan

astrazeneca-plc

0 rujukan

Central Index Key ^Inggeris

1 rujukan

Polygon.io ^Inggeris

Astrazeneca PLC

20 Februari 2021

CNA topic ID ^Inggeris

astrazeneca

1 rujukan

https://www.channelnewsasia.com/news/topic/astrazeneca

ASTRAZENECA latest news & coverage (Inggeris)

20 Julai 2021

Companies House company ID ^Inggeris

02723534

0 rujukan

Comparably company ID ^Inggeris

astrazeneca-plc

1 rujukan

https://www.comparably.com/companies/astrazeneca-plc

Astrazeneca PLC Company Culture | Comparably (Inggeris)

pengecam pertubuhan Crunchbase

4 Mac 2022

astrazeneca

2 rujukan

Crunchbase ^Inggeris

http://km.aifb.kit.edu/services/crunchbase/

D-U-N-S number ^Inggeris

230790719

0 rujukan

ID topik Dagens Nyheter

0 rujukan

AstraZeneca

0 rujukan

ID Den Store Danske

AstraZeneca

0 rujukan

EU Transparency Register ID ^Inggeris

42561875992-94

sebab disisihkan

withdrawn identifier value ^Inggeris

0 rujukan

249402638316-62

dinyatakan sebagai

AstraZeneca PLC

1 rujukan

Jun 2023

1 rujukan

Graf Pengetahuan Google

30 September 2020

1 rujukan

Longgokan Data Freebase

tarikh penerbitan

28 Oktober 2013

Glassdoor company ID ^Inggeris

9214

1 rujukan

https://www.glassdoor.sg/Overview/Working-at-AstraZeneca-EI_IE9214.11,22.htm?countryRedirect=true

Working at AstraZeneca | Glassdoor (Inggeris)

7 November 2021

Golden ID ^Inggeris

AstraZeneca-PY54V

1 rujukan

10 September 2022

https://golden.com/wiki/AstraZeneca-PY54V

Google Scholar organization ID ^Inggeris

992515209104559621

0 rujukan

Great Russian Encyclopedia portal ID ^Inggeris

astrazeneca-a9c2fa

0 rujukan

ID GRID

grid.417815.e

2 rujukan

GRID Release 2015-12-14 ^Inggeris

GRID Release 2016-12-06 ^Inggeris

nama pengguna Instagram

astrazeneca

1 rujukan

https://www.linkedin.com/company/astrazeneca/

Graf Pengetahuan Google

30 September 2020

1 rujukan

AstraZeneca: Overview | LinkedIn (Inggeris)

4 Ogos 2021

ID Microsoft Academic

0 rujukan

0 rujukan

1 rujukan

grid.417815.e

pengecam OpenCorporates

gb/02723534

0 rujukan

PermID ^Inggeris

0 rujukan

1 rujukan

AstraZeneca UK Ltd

1 rujukan

Aligned ISNI and Ringgold identifiers for institutions ^Inggeris

4625

AstraZeneca plc

1 rujukan

Aligned ISNI and Ringgold identifiers for institutions ^Inggeris

0 rujukan

AstraZeneca

0 rujukan

ID tesaurus Parlimen UK

2690

AstraZeneca

0 rujukan

University of Barcelona authority ID ^Inggeris

981058513598106706

1 rujukan

ID VIAF

154100491

Vedomosti company ID ^Inggeris

astrazeneca-

0 rujukan

nama pengguna Twitter

AstraZeneca

bilangan pelanggan

142,600